THE QMS MAY SHOW
That the workflow was completed.
- Investigation closed
- CAPA action completed
- Batch disposition recorded
- Change approved
- Electronic signature captured
FDA Inspection Readiness
ComplianceWorxs creates the record behind consequential GMP decisions—preserving the evidence, judgment, risk, and accountable authorization a later reviewer needs to understand why the decision was made.
Start with the problem you recognize. Move to the record only when the decision warrants it.
What ComplianceWorxs provides
ComplianceWorxs works alongside the existing QMS to preserve the evidence available at the time, the judgment applied, the risk and alternatives considered, and the accountable authorization behind a completed decision.
The output: a reviewable record that shows not only what was decided, but why the decision was authorized—without requiring a later reviewer to reconstruct the answer from attachments, meetings, email, and memory.
The readiness distinction
A workflow can be complete, signatures can be present, and the final disposition can be recorded while the basis for the decision remains dispersed across attachments, systems, meetings, and individual memory.
Inspection readiness improves when the decision can stand on its own. Another qualified reviewer should be able to retrieve the record and understand the chain from evidence to authorization without reconstructing what happened later.
THE QMS MAY SHOW
THE REVIEWER MAY STILL NEED
The record behind the decision
The point is not to create another layer of documentation. It is to preserve the minimum decision trail a later reviewer needs to understand why the organization proceeded.
What records, data, observations, and facts informed the decision.
How the available information was evaluated against the relevant standard or decision criteria.
What uncertainty, alternatives, residual risk, and controls were weighed.
Who accepted the outcome and why that person or role held the decision authority.
Where the record matters
ComplianceWorxs can be applied to a completed GMP decision where a later reviewer must understand more than the workflow status. Begin with one decision—such as a batch disposition, deviation closure, CAPA effectiveness determination, change-control approval, OOS conclusion, or supplier authorization—and create the retrievable record behind it.
See a completed Decision Record →The retrieval test
That does not automatically mean the underlying decision was wrong. It means the organization may be unable to demonstrate the basis efficiently from the record that exists today.
TRY THIS WITH ONE COMPLETED DECISION
If those answers require interviews, email searches, or memory, the decision record may not stand on its own.
Use the five-minute inspection-readiness self-check →Proof before product
ComplianceWorxs Case Files show completed, scenario-specific examples of the record behind consequential Quality decisions. They let a leader inspect the structure and reasoning before applying the approach to an actual organizational decision.
FDA context
FDA explains that inspection observations may be documented on Form FDA 483 when observed conditions or practices may indicate a violation of FDA requirements, and that a Form 483 is not a final agency determination.
FDA's CGMP records-and-reports materials also explain that records needed to demonstrate CGMP compliance are subject to inspection. ComplianceWorxs focuses on the practical leadership question inside those records: can the organization explain the consequential decisions they contain?
Apply the test to one real decision
For one completed GMP decision, ComplianceWorxs preserves the evidence, judgment, risk, and accountable authorization in a reviewable record designed to stand without reconstruction.